These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11981736)

  • 41. A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy.
    Bezemer D; de Wolf F; Boerlijst MC; van Sighem A; Hollingsworth TD; Prins M; Geskus RB; Gras L; Coutinho RA; Fraser C
    AIDS; 2008 May; 22(9):1071-7. PubMed ID: 18520351
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced women.
    Tuomala RE; O'Driscoll PT; Bremer JW; Jennings C; Xu C; Read JS; Matzen E; Landay A; Zorrilla C; Blattner W; Charurat M; Anderson DJ;
    J Infect Dis; 2003 Feb; 187(3):375-84. PubMed ID: 12552421
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immune-based prevention of mother-to-child HIV-1 transmission.
    Gray GE; Tiemessen CT; de Bruyn G
    Curr Opin Mol Ther; 2007 Apr; 9(2):168-75. PubMed ID: 17458171
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Care and management of the infant of the HIV-1-infected mother.
    Paintsil E; Andiman WA
    Semin Perinatol; 2007 Apr; 31(2):112-23. PubMed ID: 17462496
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HIV postexposure prophylaxis after sexual assault.
    Stevens L; Brown MA
    Nurse Pract Forum; 2001 Dec; 12(4):192-8. PubMed ID: 11889687
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Post-exposure prevention of HIV-1 infection.
    Kahn JO
    Antivir Ther; 1998; 3 Suppl 4():45-7. PubMed ID: 10723509
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [News in HIV/AIDS therapy].
    Calmy A; Cavassini M
    Rev Med Suisse; 2012 Jan; 8(324):130-4. PubMed ID: 23185824
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Does antiretroviral therapy prevent HIV transmission to sexual partners?
    Lalani T; Hicks C
    Curr HIV/AIDS Rep; 2007 May; 4(2):80-5. PubMed ID: 17547829
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services.
    Smith DK; Grohskopf LA; Black RJ; Auerbach JD; Veronese F; Struble KA; Cheever L; Johnson M; Paxton LA; Onorato IM; Greenberg AE;
    MMWR Recomm Rep; 2005 Jan; 54(RR-2):1-20. PubMed ID: 15660015
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Measuring the infectiousness of persons with HIV-1: opportunities for preventing sexual HIV-1 transmission.
    Baeten JM; Overbaugh J
    Curr HIV Res; 2003 Jan; 1(1):69-86. PubMed ID: 15043213
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nonoccupational Postexposure Prophylaxis and Preexposure Prophylaxis for Human Immunodeficiency Virus Prevention in Adolescents and Young Adults.
    Straub DM; Mullins TLK
    Adv Pediatr; 2019 Aug; 66():245-261. PubMed ID: 31230697
    [No Abstract]   [Full Text] [Related]  

  • 52. The sexual health needs of HIV-positive people.
    Hutchinson J; Estcourt C; Imrie J; Fenton KA
    Int J STD AIDS; 2003 Jul; 14(7):500-1. PubMed ID: 12869235
    [No Abstract]   [Full Text] [Related]  

  • 53. Response to "Increased reporting of male-to-male sexual activity in a national survey".
    Beltrami JF
    Sex Transm Dis; 2003 Jun; 30(6):526-7. PubMed ID: 12782956
    [No Abstract]   [Full Text] [Related]  

  • 54. Antiretroviral agents used by HIV-uninfected persons for prevention: pre- and postexposure prophylaxis.
    Grant RM
    Clin Infect Dis; 2010 May; 50 Suppl 3(Suppl 3):S96-101. PubMed ID: 20397962
    [TBL] [Abstract][Full Text] [Related]  

  • 55. British HIV Association, BASHH and FSRH guidelines for the management of the sexual and reproductive health of people living with HIV infection 2008.
    Fakoya A; Lamba H; Mackie N; Nandwani R; Brown A; Bernard E; Gilling-Smith C; Lacey C; Sherr L; Claydon P; Wallage S; Gazzard B
    HIV Med; 2008 Oct; 9(9):681-720. PubMed ID: 18983476
    [No Abstract]   [Full Text] [Related]  

  • 56. The human immunodeficiency virus, (HIV-1), pandemic: cellular therapies, stem cells and biobanking.
    Stephens LL; Swanepoel CC; Van Rooyen BA; Abayomi EA
    Transfus Apher Sci; 2013 Aug; 49(1):9-11. PubMed ID: 23769172
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacologic management of HIV/STD exposure.
    Moran GJ
    Emerg Med Clin North Am; 2000 Nov; 18(4):829-42, viii. PubMed ID: 11130941
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors affecting sexual transmission of HIV-1: current evidence and implications for prevention.
    Chan DJ
    Curr HIV Res; 2005 Jul; 3(3):223-41. PubMed ID: 16022655
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stay current with options for HIV prevention.
    Baker J
    JAAPA; 2013 Dec; 26(12):14-20; quiz 25. PubMed ID: 24177333
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human immunodeficiency virus prevention strategies in China.
    Wu ZY; Scott SR
    Chin Med J (Engl); 2020 Feb; 133(3):318-325. PubMed ID: 31929359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.